VANCOUVER, Oct. 24, 2018 /PRNewswire/ – THC BioMed (CSE: THC) is pleased to announce its third shipment to the British Columbia Liquor Distribution Branch (BCLDB).

THC BioMed is delighted that its strains and pre-rolls are sold out due to popular demand and looks forward to the continuation of providing the adult use recreational market with high-quality cannabis for a reasonable price.

About THC BioMed

THC BioMed’s vision is to be on the leading edge of scientific research, development of products and services related to the medical cannabis industry while creating a standard of excellence. As the industry develops, it will become more important to focus on scientific research and development of products and services related to medical cannabis. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry.

Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com

Forward-Looking Information:
This press release may include forward-looking information within the meaning of Canadian securities legislation, concerning the business of THC.  Forward-looking information is based on certain key expectations and assumptions made by the management of THC.  In some cases, you can identify forward-looking statements by the use of words such as “will,” “may,” “would,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “could” and variations of these terms and similar expressions, or the negative of these terms or similar expressions.  Although THC believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because THC can give no assurance that they will prove to be correct.  Forward-looking statements contained in this press release are made as of the date of this press release include that THC will continue to provide the adult use recreational market with high quality cannabis for a reasonable price.  THC disclaims any intent or obligation to update publicly any forward-looking information, whether as a result of new information, future events or results or otherwise, other than as required by applicable securities laws.

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/thc-biomed-ships-more-cannabis-products-to-british-columbia-liquor-distribution-branch-to-restock-sold-out-products-300737292.html

SOURCE THC BioMed